Non-Current Liabilities
Deferred Tax Liabilities
Merck & Co. Deferred Tax Liabilities decreased by 8.9% to $338M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 8.9%, from $371M to $338M. Over 5 years (FY 2020 to FY 2025), Deferred Tax Liabilities shows an upward trend with a 6.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Liabilities
CategoryRisk
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ4 2025Feb 24, 2026
How to read this metric
An increase indicates that the company has deferred tax payments to future periods, which can act as a source of temporary liquidity.
Detailed definition
These represent tax obligations that are expected to be paid in future periods due to temporary differences between the...
Peer comparison
Common in capital-intensive industries where accelerated depreciation for tax purposes creates significant temporary differences.
Metric ID:
deferred_tax_liabilitiesHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $338M | $284M | $118M | $371M | $338M |
| QoQ Change | — | -16.0% | -58.5% | +214.4% | -8.9% |
| YoY Change | — | -16.0% | -58.5% | +214.4% | -8.9% |
Range$118M – $371M
CAGR+0.0%
Avg YoY Growth+32.8%
Median YoY Growth-12.4%
Deferred Tax Liabilities at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s deferred tax liabilities?
- Merck & Co. (MRK) reported deferred tax liabilities of $338M in Q4 2025.
- How has Merck & Co.'s deferred tax liabilities changed year-over-year?
- Merck & Co.'s deferred tax liabilities decreased by 8.9% year-over-year, from $371M to $338M.
- What is the long-term trend for Merck & Co.'s deferred tax liabilities?
- Over 5 years (2020 to 2025), Merck & Co.'s deferred tax liabilities has grown at a 6.4% compound annual growth rate (CAGR), from $248M to $338M.
- What does deferred tax liabilities mean?
- Future tax payments resulting from differences between accounting rules and tax laws.